Fundsmith Equity Fund’s Idexx Laboratories IDXX Stock Holding History

Fundsmith Equity Fund’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$965M	Buy	+4,429,104	New	+$913M	7.18%	4

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Fundsmith Equity Fund's IDXX Position: Q2 2018 in Review

Fundsmith Equity Fund opened a new position in Idexx Laboratories (IDXX) in Q2 2018: 4,429,104 shares worth $965M. The stake represents 7.18% of the portfolio and ranks #4 among its holdings.

665 funds tracked by Wall St. Rank hold IDXX as of Q2 2018.

Fundsmith Equity Fund held 4,429,104 shares of Idexx Laboratories worth $965M as of Q2 2018.
Idexx Laboratories was a new Fundsmith Equity Fund position in Q2 2018.
Idexx Laboratories made up 7.18% of Fundsmith Equity Fund's portfolio in Q2 2018, its #4 holding.
665 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2018.

Based on Fundsmith Equity Fund's 13F filing for Q2 2018, filed 14 Aug 2018.